Latham & Watkins LLP represented Evelo Biosciences in the offering. Evelo Biosciences, Inc., a clinical stage biotechnology company developing orally delivered, systemically acting biologic therapies, has…
Evelo Biosciences’ $45 Million Common Stock Offering
